Table 8. Differences of mean scores of subscales: Comparisons between two known-groups with the Karnofsky Performance Status score ≧70 or <70 subgroups among patients completed questionnaires prior to their first cycle of treatment (T1), and the second column is among patients completed questionnaires on the last day of the first cycle of treatment (T2).
| Scales/items | T1 | T2 | ||
|
|
|
|||
| Difference | p | Difference | p | |
| physical functioning (PF) | -22.0 | 0.0116 | -21.1 | 0.0001 |
| role functioning (RF) | -24.2 | 0.0006 | -15.0 | 0.0216 |
| emotional functioning (EF) | -12.3 | 0.0236 | -14.1 | 0.0035 |
| cognitive functioning (CF) | -11.8 | 0.0386 | -14.2 | 0.0157 |
| social functioning (SF) | -20.4 | 0.0014 | -8.6 | 0.1427 |
| global health/QOL (QL) | -10.5 | 0.0467 | -6.1 | 0.1560 |
| fatigue (FA) | 23.5 | 0.0000 | 18.0 | 0.0020 |
| nausea and vomiting (NV) | 11.6 | 0.0793 | 12.7 | 0.0640 |
| pain (PA) | 17.2 | 0.0526 | 20.3 | 0.0033 |
| dyspnea (DY) | 11.2 | 0.2098 | 14.9 | 0.0090 |
| sleep disturbance (SL) | 14.4 | 0.0310 | 16.9 | 0.0056 |
| appetite loss (AP) | 23.1 | 0.0013 | 20.8 | 0.0008 |
| constipation (CO) | 17.8 | 0.0087 | 9.0 | 0.1875 |
| diarrhea (DI) | -2.4 | 0.6237 | -6.2 | 0.2220 |
| financial impact (FI) | 9.4 | 0.2046 | 4.3 | 0.5096 |